FDA Drug · D-0498-2024

Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44

Class II · Ongoing

Presence of foreign substance: plastic-like substance.

Affected lots / codes — check yours against thisLot #: BLK2304A, Exp. 07/31/2025

Recalling firm: MACLEODS PHARMA USA, INC, Princeton, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 1,048 bottles
Distribution: USA Nationwide
Recall initiated: May 7, 2024
Classified: May 15, 2024
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0498-2024%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

See every recall for this brand: Is LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE recalled? →

Check this brand across all 8 databases →